(Q40409535)

20 September 2017

Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans (English)

1 reference

20 September 2017

Joshua A Lile

1

1 reference

20 September 2017

William W Stoops

2

1 reference

20 September 2017

Andrea R Vansickel

3

1 reference

20 September 2017

Paul E A Glaser

4

1 reference

20 September 2017

Lon R Hays

5

1 reference

20 September 2017

Craig R Rush

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

20 September 2017

Neuropsychopharmacology

1 reference

20 September 2017

30

1 reference

20 September 2017

11

1 reference

20 September 2017

2103-2114

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300803

20 September 2017

0 references

cites work

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

The discriminative stimulus and subjective effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Dopamine receptor partial agonists could address the duality of cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Reinstatement of cocaine-reinforced responding in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Combating opiate dependence: a comparison among the available pharmacological options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Effects of the NMDA antagonist memantine on human methamphetamine discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Discriminative stimulus properties of d-amphetamine in pigeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Biological basis of sex differences in drug abuse: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Dopamine partial agonist reverses amphetamine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Effects of central and peripheral nicotinic blockade on human nicotine discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Alprazolam attenuates the behavioral effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Exploring the prevalence and correlates of methamphetamine use: findings from Sacramento's ADAM program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

1 reference

7 January 2021

Amphetamine discrimination: effects of dopamine receptor agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

7 January 2021

Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300803

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300803

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference